首页|参附强心丸辅治慢性心力衰竭临床观察

参附强心丸辅治慢性心力衰竭临床观察

扫码查看
目的:观察参附强心丸辅治慢性心力衰竭的疗效。方法:92例分为两组,对照组45例用西药治疗,观察组47例用参附强心丸及西药治疗。结果:总有效率观察组比对照组高(P<0。05)。两组治疗后中医证候积分均下降,且观察组比对照组低(P<0。05)。治疗后两组ET-1及炎性因子hs-CRP、TNF-α均降低,且观察组比对照组低(P<0。05)。两组不良反应发生率比较差异无统计学意义(P>0。05)。结论:参附强心丸辅治慢性心力衰竭疗效较好,且安全。
Objective:To observe the curative effect of Shenfu Qiangxin Pills in adjuvant treatment of chronic heart failure.Methods:Ninety-two cases were divided into two groups.Forty-five cases in the control group were treated with western medicine while forty-seven cases in the observation group were treated with Shenfu Qiangxin Pills and western medicine.Results:The total effective rate of the observation group was higher than that of the control group(P<0.05).After treatment,the scores of TCM syndromes in both groups decreased,and those in the observation group were lower than the control group(P<0.05).After treatment,ET-1 and inflammatory factors hs-CRP and TNF-α in the two groups decreased,and those in the observation group were lower than the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Shenfu Qiangxin Pills is effective and safe in the treatment of chronic heart failure.

Chronic heart failureShenfu Qiangxin PillsControl treatment and observation

熊珊、赵英丽、韩硕

展开 >

南阳医学高等专科学校第一附属医院全科医学科,河南 南阳 473000

河南省南阳市中心医院产科,河南 南阳 473005

慢性心力衰竭 参附强心丸 对照治疗观察

2024

实用中医药杂志
重庆医科大学中医药学院

实用中医药杂志

影响因子:0.546
ISSN:1004-2814
年,卷(期):2024.40(7)